|
RNF219 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.775900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.356210E-03 |
| Normal-vs-Stage2 |
1.116430E-02 |
| Normal-vs-Stage3 |
1.724580E-03 |
| Normal-vs-Stage4 |
5.90329999999861E-05 |
| Stage1-vs-Stage2 |
8.299200E-01 |
| Stage1-vs-Stage3 |
7.513400E-01 |
| Stage1-vs-Stage4 |
1.250190E-01 |
| Stage2-vs-Stage3 |
9.891200E-01 |
| Stage2-vs-Stage4 |
4.481800E-01 |
| Stage3-vs-Stage4 |
3.108800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.225000E-04 |
| Normal-vs-AfricanAmerican |
3.709900E-02 |
| Normal-vs-Asian |
5.482300E-02 |
| Caucasian-vs-AfricanAmerican |
9.585600E-01 |
| Caucasian-vs-Asian |
3.375000E-01 |
| AfricanAmerican-vs-Asian |
5.702400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.363460E-03 |
| Normal-vs-Female |
4.983100E-04 |
| Male-vs-Female |
7.721200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.203000E-03 |
| Normal-vs-Age(41-60Yrs) |
5.984400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.235100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.220800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.265400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.676200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.631700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.461800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.136010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.793810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.483800E-01 |
| Classical-VS-Follicular |
1.115720E-03 |
| Classical-VS-Other |
2.521800E-01 |
| Classical-VS-Normal |
8.800400E-03 |
| Tall-VS-Follicular |
2.406600E-01 |
| Tall-VS-Other |
4.761800E-01 |
| Tall-VS-Normal |
1.725940E-02 |
| Follicular-VS-Other |
9.843800E-01 |
| Follicular-VS-Normal |
4.25820000000687E-05 |
| Other-VS-Normal |
4.194400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.417200E-04 |
| Normal-vs-N1 |
3.791100E-04 |
| N0-vs-N1 |
3.920800E-01 |
|
|
